EUVIMEDEUVIMED entdecken
Crossref

Antenatal risk stratification for preeclampsia with sFlt-1/PlGF ratio: Which is the best time to test?

Manisha Kumar, Kirti Balyan, Ekta Debnath, Ben Himtsoe, Surbhi Sapna, Arunav Kumar

Pregnancy Hypertension · 2023

DOI: 10.1016/j.preghy.2023.09.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pregnancy Hypertension, 2023. Verfasst von Manisha Kumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, LHMC, New Delhi, India. Electronic address: manishaonly@gmail.com. Hauptthemen laut MEDLINE: Pre-Eclampsia, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To find out the predictive value of sFlt-1/PlGF ratio for antenatal risk stratification (ARS) of women at high risk of preeclampsia (PE). METHODS: Antenatal women at high risk of PE underwent sFlt-1/PlGF ratio at 20-22, 28-30 and 34-36 weeks and were followed till delivery. Those who developed PE were cases those who had normal outcome were controls, the cases and controls were compared. RESULTS: Hypertension in pregnancy was seen in 116/287 (40.4 %), 46/287(16.0 %) had PE and 21(7.3 %) had early onset PE. Mean arterial pressure at 20-22 weeks was the high in those who developed early onset PE (109.08 ± 9.74 mmHg). The sFlt-1/PlGF ratio of 38 or more at 20-22 weeks resulted in either PE or adverse fetal outcome in all cases. Whereas, the ratio of less than 38 ruled out PE in all cases up to 29 + 6 weeks. At 28-30 weeks, the ratio less than 38 predicted no PE up to 34 weeks and no complication up to 29+6 weeks. The sensitivity for the detection at later gestation further decreased as the gestation advanced however the specificity was above 98 % at all gestations. The positive predictive value of the test increased with the advancing gestation, the negative predictive value was 93 % or higher at all gestations. CONCLUSION: The usefulness of sFlt-1/PlGF ratio ≥38 for risk stratification was validated in the study, the testing at 28-30 weeks appeared to be the best time to test for PE prediction in high risk women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaHypertensionPregnancyFemaleHumansBiomarkersPlacenta Growth FactorPredictive Value of TestsVascular Endothelial Growth Factor Receptor-1Risk Assessment

Stichwörter der Autor:innen

BiomarkersEarly onset preeclampsiaHypertension in pregnancyIndiaPreeclampsia prediction

Substanzen

BiomarkersPlacenta Growth FactorVascular Endothelial Growth Factor Receptor-1

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, LHMC, New Delhi, India. Electronic address: manishaonly@gmail.com.
  • Department of Obstetrics and Gynecology, LHMC, New Delhi, India.
  • Department of Biochemistry, LHMC, New Delhi, India.
  • Kasturba Medical College, Manipal, Karnataka, India.

Zitieren

APA

Kumar, M., Balyan, K., Debnath, E., Himtsoe, B., Sapna, S., & Kumar, A. (2023). Antenatal risk stratification for preeclampsia with sFlt-1/PlGF ratio: Which is the best time to test?. Pregnancy Hypertension. https://doi.org/10.1016/j.preghy.2023.09.005

Vancouver

Kumar M, Balyan K, Debnath E, Himtsoe B, Sapna S, Kumar A. Antenatal risk stratification for preeclampsia with sFlt-1/PlGF ratio: Which is the best time to test?. Pregnancy Hypertension. 2023. doi:10.1016/j.preghy.2023.09.005

BibTeX
@article{Kumar2023,
  author = {Kumar, Manisha and Balyan, Kirti and Debnath, Ekta and Himtsoe, Ben and Sapna, Surbhi and Kumar, Arunav},
  title = {Antenatal risk stratification for preeclampsia with sFlt-1/PlGF ratio: Which is the best time to test?},
  journal = {Pregnancy Hypertension},
  year = {2023},
  doi = {10.1016/j.preghy.2023.09.005}
}
Kostenlos starten →